Literature DB >> 25048878

Synergic effects of artemisinin and resveratrol in cancer cells.

Peichun Li1, Sen Yang, Mengmeng Dou, Youran Chen, Jie Zhang, Xiaoyan Zhao.   

Abstract

PURPOSE: The aim of this study was to investigate whether resveratrol (Res) combined with artemisinin (ART) possess synergistic effect on different cancer cells.
MATERIALS AND METHODS: The viability of HepG2 and HeLa cells treated with ART and Res was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Combination index (CI) analysis and isobologram were used to assess the synergistic effect of ART and Res in different ratios. Wound-healing assay was used to investigate the migration rate. AO staining and fluorescent microscopy measurements were performed to detect the cell apoptosis. Reactive oxygen species (ROS) was measured with 2'7'-dichlorofluorescein diacetate (DCFH-DA).
RESULTS: MTT assay indicated that ART and Res inhibited the growth of HeLa and HepG2 cells in a dose-dependent manner. The combination of ART and Res exhibited the strongest anticancer effect at the ratio of 1:2 (ART to Res). The combination of the two drugs also markedly reduced the ability of cell migration. Apoptosis analysis showed that combination of ART and Res significantly increased the apoptosis and necrosis rather than use singly. Additionally, ROS levels were elevated by combining ART with Res.
CONCLUSIONS: Taken together, the present study suggested that ART and Res possessed the synergistic anti-tumor effect. ART in combination with Res could be an effective therapeutic strategy for cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25048878     DOI: 10.1007/s00432-014-1771-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  42 in total

1.  Resveratrol plays dual roles in pancreatic cancer cells.

Authors:  Lei Yang; Liang Yang; Wencong Tian; Jing Li; Jie Liu; Mengmeng Zhu; Yan Zhang; Yinan Yang; Fei Liu; Qiong Zhang; Qianqian Liu; Yanna Shen; Zhi Qi
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-07       Impact factor: 4.553

Review 2.  Development of artemisinin compounds for cancer treatment.

Authors:  Henry C Lai; Narendra P Singh; Tomikazu Sasaki
Journal:  Invest New Drugs       Date:  2012-08-31       Impact factor: 3.850

3.  Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  H Xu; Y He; X Yang; L Liang; Z Zhan; Y Ye; X Yang; F Lian; L Sun
Journal:  Rheumatology (Oxford)       Date:  2007-02-21       Impact factor: 7.580

Review 4.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anjana Bhardwaj; Rishi S Aggarwal; Navindra P Seeram; Shishir Shishodia; Yasunari Takada
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

Review 5.  Resveratrol and its analogues: promising antitumor agents.

Authors:  Xianfeng Huang; Hai-Liang Zhu
Journal:  Anticancer Agents Med Chem       Date:  2011-06       Impact factor: 2.505

6.  Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells.

Authors:  Md Asaduzzaman Khan; Han-Chun Chen; Xin-Xing Wan; Mousumi Tania; Ai-Hua Xu; Fang-Zhi Chen; Dian-Zheng Zhang
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

7.  Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.

Authors:  Junmei Hou; Disong Wang; Ruiwen Zhang; Hui Wang
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

8.  Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression.

Authors:  P Liu; H Liang; Q Xia; P Li; H Kong; P Lei; S Wang; Z Tu
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

9.  Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.

Authors:  Henry Lai; Ikuhiko Nakase; Eric Lacoste; Narendra P Singh; Tomikazu Sasaki
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

10.  Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.

Authors:  Chiara Riganti; Sophie Doublier; Costanzo Costamagna; Elisabetta Aldieri; Gianpiero Pescarmona; Dario Ghigo; Amalia Bosia
Journal:  Mol Pharmacol       Date:  2008-05-07       Impact factor: 4.436

View more
  9 in total

Review 1.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

2.  Norcantharidin combined with 2-deoxy-d-glucose suppresses the hepatocellular carcinoma cells proliferation and migration.

Authors:  Ragini Singh; Shuang Cheng; Jun Li; Santosh Kumar; Qinghua Zeng; Qingmei Zeng
Journal:  3 Biotech       Date:  2021-02-25       Impact factor: 2.406

Review 3.  Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma.

Authors:  Akiko Kojima-Yuasa; Xuedan Huang; Isao Matsui-Yuasa
Journal:  Diseases       Date:  2015-10-22

4.  The Effects of 4'-Esterified Resveratrol Derivatives on Calcium Dynamics in Breast Cancer Cells.

Authors:  Joshua A Peterson; Hayden P Doughty; Austin J Eells; Trent A Johnson; Jordan P Hastings; Colton M Crowther; Merritt B Andrus; Jason D Kenealey
Journal:  Molecules       Date:  2017-11-14       Impact factor: 4.411

Review 5.  Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy.

Authors:  Jiabing Wang; Dongsheng Sun; Lili Huang; Shijian Wang; Yong Jin
Journal:  Oxid Med Cell Longev       Date:  2021-09-07       Impact factor: 6.543

6.  Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma.

Authors:  Zhouyu Ning; Yingke Zhao; Xia Yan; Yongqiang Hua; Zhiqiang Meng
Journal:  Nanomaterials (Basel)       Date:  2022-06-15       Impact factor: 5.719

Review 7.  Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer.

Authors:  Xue-Qing Hu; Yang Sun; Eric Lau; Ming Zhao; Shi-Bing Su
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

Review 8.  Antitumor Research on Artemisinin and Its Bioactive Derivatives.

Authors:  Yunqin Zhang; Guowei Xu; Shuqun Zhang; Dong Wang; P Saravana Prabha; Zhili Zuo
Journal:  Nat Prod Bioprospect       Date:  2018-04-09

Review 9.  Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues.

Authors:  Danielly C Ferraz da Costa; Luciana Pereira Rangel; Mafalda Maria Duarte da Cunha Martins-Dinis; Giulia Diniz da Silva Ferretti; Vitor F Ferreira; Jerson L Silva
Journal:  Molecules       Date:  2020-02-18       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.